Site icon Healthy.net

New Epstein-Barr Treatment Shows Promise for CFS & Fibromyalgia

Woman feeling fatigue and holding arms

new study using sensitive PCR testing found that 24% of people with CFS/ME tested positive for Epstein-Barr virus (EBV) compared to only 4% of healthy people. The testing showed cytomegalovirus (CMV) positive in 3.4% of cases and HHV-6 positive in 1.7% of cases. That compared to 0% positive of either in healthy people. Fifty-eight people were in the CFS group, while 50 were in the healthy control group.

These findings are consistent with a 2017 study by Dr. William Pridgen that suggested taking the anti-EBV medications Famvir and Celebrex for six months can help a subset of people with CFS and fibromyalgia. I’ve also seen this in thousands of people that I’ve treated.

Meanwhile, another recent study shows that an old diuretic called spironolactone (Aldactone) is also active against Epstein-Barr syndrome. Combining it with other antiviral treatments may enhance their effectiveness, although this must be done cautiously, as the diuretic can lower both testosterone and blood volume. And both of these are already low in people with fibromyalgia.

The price of spironolactone treatment is only $0.20 a day. For most healthy people, it’s also quite safe. However, there are concerns using it to treat CFS/FMS:

Bottom Line?

Spironolactone offers another potential tool for treating people whose CFS and fibromyalgia began with an acute viral infection, have the severe form that leaves them housebound, or who have chronic flu-like symptoms. However, it needs to be used cautiously for the reasons noted above. Fortunately, simple measures can prevent these problems.

Exit mobile version